The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butz, E. A.
Right arrow Articles by Bevan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butz, E. A.
Right arrow Articles by Bevan, M. J.
The Journal of Immunology, 1998, 160: 2139-2144.
Copyright © 1998 by The American Association of Immunologists

Differential Presentation of the Same MHC Class I Epitopes by Fibroblasts and Dendritic Cells

Eric A. Butz and Michael J. Bevan

Howard Hughes Medical Institute and Department of Immunology, University of Washington, Seattle, WA 98195

Ag is presented to CTL as peptide associated with MHC class I molecules, which are present on most types of cells. We have investigated the presentation of Db-restricted lymphocytic choriomeningitis virus (LCMV) peptides by a fibroblast line (MC57) and a dendritic cell line (JawsII) to splenocytes from LCMV-immune C57BL/6 mice. We found that when LCMV-infected MC57 were used to restimulate the spleen cells, the resulting CTL line lost its ability to respond to the two dominant epitopes of the immune response to LCMV glycoprotein (gp)33 and nucleoprotein (np)396 but remained strongly lytic for targets coated with the subdominant gp276 epitope. In contrast, when LCMV-infected JawsII cells were used to restimulate the splenocytes, the resulting line continued to target gp33 and np396 but lost reactivity to gp276. When uninfected JawsII or MC57 cells were coated with peptides and used as stimulators, the resulting CTL lines continued to recognize all three epitopes, indicating that costimulatory or other potential innate differences in Ag presentation between the two cell lines are unlikely to account for the selective expansion of CTL specificities. When infected, both cell types produce similar levels of infectious LCMV, have similar levels of the NP and GP proteins from which np396 and gp33 are derived, and can be recognized by CTL specific for each of the three epitopes. These data indicate that in the generation of peptides for MHC-I binding and presentation to CTL, MC57 and JawsII process the same set of virus proteins in quantitatively different ways.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. R. Jenkins, R. Webby, P. C. Doherty, and S. J. Turner
Addition of a Prominent Epitope Affects Influenza A Virus-Specific CD8+ T Cell Immunodominance Hierarchies When Antigen Is Limiting.
J. Immunol., September 1, 2006; 177(5): 2917 - 2925.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chapiro, S. Claverol, F. Piette, W. Ma, V. Stroobant, B. Guillaume, J.-E. Gairin, S. Morel, O. Burlet-Schiltz, B. Monsarrat, et al.
Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation
J. Immunol., January 15, 2006; 176(2): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. E. Tebo, M. J. Fuller, D. E. Gaddis, K. Kojima, K. Rehani, and A. J. Zajac
Rapid Recruitment of Virus-Specific CD8 T Cells Restructures Immunodominance during Protective Secondary Responses
J. Virol., October 15, 2005; 79(20): 12703 - 12713.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L.-A. M. Pozzi, J. W. Maciaszek, and K. L. Rock
Both Dendritic Cells and Macrophages Can Stimulate Naive CD8 T Cells In Vivo to Proliferate, Develop Effector Function, and Differentiate into Memory Cells
J. Immunol., August 15, 2005; 175(4): 2071 - 2081.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Otahal, S. C. Hutchinson, L. M. Mylin, M. J. Tevethia, S. S. Tevethia, and T. D. Schell
Inefficient Cross-Presentation Limits the CD8+ T Cell Response to a Subdominant Tumor Antigen Epitope
J. Immunol., July 15, 2005; 175(2): 700 - 712.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kummer, A. Lev, Y. Reiter, and B. C. Biedermann
Vascular Endothelial Cells Have Impaired Capacity to Present Immunodominant, Antigenic Peptides: A Mechanism of Cell Type-Specific Immune Escape
J. Immunol., February 15, 2005; 174(4): 1947 - 1953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Hearn, L. de Haan, A. J. Pemberton, T. R. Hirst, and A. J. Rivett
Trafficking of Exogenous Peptides into Proteasome-dependent Major Histocompatibility Complex Class I Pathway following Enterotoxin B Subunit-mediated Delivery
J. Biol. Chem., December 3, 2004; 279(49): 51315 - 51322.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Basler, N. Youhnovski, M. van den Broek, M. Przybylski, and M. Groettrup
Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus
J. Immunol., September 15, 2004; 173(6): 3925 - 3934.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Khanolkar, M. J. Fuller, and A. J. Zajac
CD4 T Cell-Dependent CD8 T Cell Maturation
J. Immunol., March 1, 2004; 172(5): 2834 - 2844.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. M. L. Hertoghs, J. H. Ellis, and I. R. Catchpole
Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA
Nucleic Acids Res., October 15, 2003; 31(20): 5817 - 5830.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Lore, M. R. Betts, J. M. Brenchley, J. Kuruppu, S. Khojasteh, S. Perfetto, M. Roederer, R. A. Seder, and R. A. Koup
Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses
J. Immunol., October 15, 2003; 171(8): 4320 - 4328.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. R. Crowe, S. J. Turner, S. C. Miller, A. D. Roberts, R. A. Rappolo, P. C. Doherty, K. H. Ely, and D. L. Woodland
Differential Antigen Presentation Regulates the Changing Patterns of CD8+ T Cell Immunodominance in Primary and Secondary Influenza Virus Infections
J. Exp. Med., August 4, 2003; 198(3): 399 - 410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Muller, F. Grunebach, A. Nencioni, and P. Brossart
Transfection of Dendritic Cells with RNA Induces CD4- and CD8-Mediated T Cell Immunity Against Breast Carcinomas and Reveals the Immunodominance of Presented T Cell Epitopes
J. Immunol., June 15, 2003; 170(12): 5892 - 5896.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
J. Virol., April 15, 2003; 77(8): 4911 - 4927.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Milazzo, V. L. Reichardt, M. R. Muller, F. Grunebach, and P. Brossart
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA
Blood, February 1, 2003; 101(3): 977 - 982.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Fuller and A. J. Zajac
Ablation of CD8 and CD4 T Cell Responses by High Viral Loads
J. Immunol., January 1, 2003; 170(1): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. U. Vogel, H. Horton, D. H. Fuller, D. K. Carter, K. Vielhuber, D. H. O'Connor, T. Shipley, J. Fuller, G. Sutter, V. Erfle, et al.
Differences Between T Cell Epitopes Recognized After Immunization and After Infection
J. Immunol., October 15, 2002; 169(8): 4511 - 4521.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Skoberne, R. Holtappels, H. Hof, and G. Geginat
Dynamic Antigen Presentation Patterns of Listeria monocytogenes-Derived CD8 T Cell Epitopes In Vivo
J. Immunol., August 15, 2001; 167(4): 2209 - 2218.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Y. Choi, Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian
Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others
J. Immunol., April 1, 2001; 166(7): 4370 - 4379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Nelson, C. Bundell, and B. Robinson
In Vivo Cross-Presentation of a Soluble Protein Antigen: Kinetics, Distribution, and Generation of Effector CTL Recognizing Dominant and Subdominant Epitopes
J. Immunol., December 1, 2000; 165(11): 6123 - 6132.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. L. Lenz, E. A. Butz, and M. J. Bevan
Requirements for Bone Marrow-derived Antigen-presenting Cells in Priming Cytotoxic T Cell Responses to Intracellular Pathogens
J. Exp. Med., October 16, 2000; 192(8): 1135 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Wang, R. Maile, R. Greenwood, E. J. Collins, and J. A. Frelinger
Naive CD8+ T Cells Do Not Require Costimulation for Proliferation and Differentiation into Cytotoxic Effector Cells
J. Immunol., February 1, 2000; 164(3): 1216 - 1222.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Montoya and M. Del Val
Intracellular Rate-Limiting Steps in MHC Class I Antigen Processing
J. Immunol., August 15, 1999; 163(4): 1914 - 1922.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. P. Dave, D. Allman, D. L. Wiest, and D. J. Kappes
Limiting TCR Expression Leads to Quantitative But Not Qualitative Changes in Thymic Selection
J. Immunol., May 15, 1999; 162(10): 5764 - 5774.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.